PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Up 50.0% in March

PURE Bioscience, Inc. (OTCMKTS:PURE) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 900 shares, a growth of 50.0% from the February 28th total of 600 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 106,200 shares, the short-interest ratio is currently 0.0 days.

PURE Bioscience Price Performance

Shares of PURE stock traded up $0.00 during trading hours on Friday, reaching $0.09. The stock had a trading volume of 95,672 shares, compared to its average volume of 65,329. The firm has a market capitalization of $10.30 million, a PE ratio of -2.30 and a beta of 0.35. The firm has a 50-day simple moving average of $0.07 and a 200-day simple moving average of $0.08. PURE Bioscience has a twelve month low of $0.05 and a twelve month high of $0.16.

PURE Bioscience (OTCMKTS:PURE) last released its quarterly earnings results on Monday, March 17th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.39 million during the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.